PUBLISHER: The Business Research Company | PRODUCT CODE: 1750997
PUBLISHER: The Business Research Company | PRODUCT CODE: 1750997
Fast melt tablets are oral dosage forms designed to dissolve quickly in the mouth without the need for water, offering a convenient alternative for patients who have difficulty swallowing traditional tablets. These tablets rapidly disintegrate, typically within seconds, upon contact with saliva. Fast melt technology is particularly useful for pediatric, geriatric, and travel-friendly medications.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The main types of fast melt tablets include antipsychotics, antiepileptics, central nervous system (CNS) stimulants, anxiolytics, anti-parkinsonian drugs, antihypertensives, non-steroidal anti-inflammatory drugs (NSAIDs), anti-allergy drugs, proton pump inhibitors, and other categories. Antipsychotics, for example, help balance brain chemicals to manage conditions such as schizophrenia and bipolar disorder, often available in fast-melt form to improve patient adherence. These tablets are used for a range of indications, such as pain management, allergy and respiratory disorders, neurological conditions, gastrointestinal issues, and cardiovascular diseases. They come in various dosage forms, including oral, sublingual, buccal, and chewable, and are used by different age groups, including adults, children, and the elderly. These products are distributed through hospital pharmacies, retail pharmacies, drug stores, and online platforms.
The fast melt tablets market research report is one of a series of new reports from The Business Research Company that provides fast melt tablets market statistics, including the fast melt tablets industry global market size, regional shares, competitors with the fast melt tablets market share, detailed fast melt tablets market segments, market trends, and opportunities, and any further data you may need to thrive in the fast melt tablets industry. This fast melt tablets market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The fast melt tablets market size has grown strongly in recent years. It will grow from$4.96 billion in 2024 to $5.38 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth during the historic period can be attributed to the rise in the geriatric population, an increase in chronic diseases, the growth in self-medication trends, the expansion of the pharmaceutical sector, and an increase in disposable income.
The fast melt tablets market size is expected to see strong growth in the next few years. It will grow to$7.35 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth during the forecast period can be attributed to the rising prevalence of dysphagia, a growing preference for over-the-counter (OTC) drugs, increasing e-commerce penetration, rising demand for oral dissolving drugs, and the expansion of healthcare infrastructure. Major trends expected in the forecast period include technological advancements, innovative formulation techniques, the integration of nanotechnology, a shift towards plant-based excipients, and the development of smart drug delivery systems.
The increasing incidence of heart attacks is expected to drive the growth of the fast melt tablets market in the coming years. A heart attack occurs when blood flow to the heart muscle is obstructed, often due to a blood clot or plaque buildup in the coronary arteries. The rising incidence of heart attacks can be attributed to higher consumption of processed foods, which contributes to elevated cholesterol levels and plaque formation in the arteries. Fast melt tablets enable rapid drug absorption, facilitating the swift delivery of essential medications such as aspirin or nitroglycerin to mitigate damage during a heart attack. This quick action helps restore blood flow, improving patient outcomes and lowering the risk of severe complications. For example, according to a report by the British Heart Foundation in January 2024, over 39,000 people in England died prematurely from cardiovascular conditions such as heart attacks, coronary heart disease, and stroke in 2022, averaging around 750 deaths per week. This represents the highest recorded figure. As such, the rising heart attack incidence is contributing to the growth of the fast melt tablets market.
Leading companies in the fast melt tablets market are focusing on developing innovative products, such as rapidly dissolving tablets that enhance patient convenience and accelerate drug absorption. Rapidly dissolving tablets (RDTs) are designed to dissolve quickly in the mouth without the need for water. For instance, in December 2022, Melt Pharmaceuticals, a US-based clinical-stage pharmaceutical company, introduced Melt 300, an advanced fast-melting tablet formulation aimed at efficient sedation. This tablet combines 3 mg of midazolam and 50 mg of ketamine, dissolving rapidly for quick onset and effective sedation without requiring intravenous administration. Targeting the growing demand for needle-free, patient-friendly sedation options, Melt 300 improves procedural comfort while optimizing clinical workflows.
In September 2023, Melt Pharmaceuticals, Inc., a US-based clinical-stage pharmaceutical company, entered into a licensing agreement with Catalent Inc. Under this partnership, Melt will utilize Catalent's proprietary Zydis orally disintegrating tablet technology to develop a sublingual, needle-free, and opioid-free formulation that combines midazolam and ketamine. Catalent Inc., a US-based company specializing in drug development and delivery solutions for biologics, gene therapies, and oral, inhalation, and injectable drug delivery technologies, will support this collaboration.
Major players in the fast melt tablets market are Pfizer Inc., Johnson & Johnson, Fuji Chemical Industries Co. Ltd., Teva Pharmaceutical Industries Ltd., Church & Dwight Co. Inc., Sun Pharmaceutical Industries Ltd, Catalent Inc., Aurobindo Pharma Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Centrient Pharmaceuticals B.V., Lannett Company Inc., Unichem Laboratories Ltd., SPI Pharma Inc., Windmill Health Products LLC, The Procter & Gamble Company, Perrigo Company plc, Melt Pharmaceuticals Inc., Imodium, Calpol, and Akina Inc.
North America was the largest region in the fast melt tablets market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in fast melt tablets report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the fast melt tablets market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The fast melt tablets market consists of sales of orally disintegrating tablets (ODTs), prescription medications, and over-the-counter (OTC) medications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Fast Melt Tablets Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on fast melt tablets market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for fast melt tablets ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The fast melt tablets market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.